Tong Dai, MD: Considering all the options, it looks like if the patient needs faster response, pembrolizumab plus lenvatinib ...
People's Insight paints a similar picture, forecasting the NDA at 133-148 seats, the MGB at 87-102 seats, JSP at 0-2 seats, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback